Mabqi
Pre-clinicalMabqi's core technology is based on proprietary fully human synthetic antibody libraries combined to AI-powered phage and yeast display technologies. We aim a discovering next generation highly developable and functional antibodies.
Founded
2017
Focus
Antibodies
About
Mabqi's core technology is based on proprietary fully human synthetic antibody libraries combined to AI-powered phage and yeast display technologies. We aim a discovering next generation highly developable and functional antibodies.
Company Info
TypePrivate
Founded2017
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile